More Varied Deal Structures Among Healthcare Providers are Another Reason Sellers Need Competitive Auctions
More Varied Deal Structures Among Healthcare Providers are Another ...
FOCUS Investment Banking Named #1 Lower Middle Market M&A Advisor In Q2 2023
FOCUS Investment Banking Named #1 Lower Middle Market M&A ...
Alzheimer’s Disease and the Growing Dementia Epidemic
Most of us know someone—relative, friend, or colleague—suffering from dementia, a medical term that describes symptoms of impaired cognition (memory and thinking), behavior, social abilities, and daily functioning. Dementia isn’t a specific disease and can range in severity from mild to severe. It has many different non-reversible and reversible causes.
Middle Market Investment Banking Firm FOCUS LLC Represents the Bioline Group of Companies in its Sale to Meridian Bioscience, Inc. Deal Marks Tenth Deal for FOCUS in 2010
Washington DC (July 23, 2010) – FOCUS LLC, a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that the Bioline group of companies has been acquired by Meridian Bioscience, Inc. (NASDAQ: VIVO). FOCUS represented Bioline in this transaction.
